The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Methylgene (Inst); Novartis (Inst); Roche (Inst)
Atezolizumab (A) + cobimetinib (C) in metastatic melanoma (mel): Updated safety and clinical activity.
 
Wilson H. Miller
No Relationships to Disclose
 
Tae Min Kim
No Relationships to Disclose
 
Carrie B. Lee
Travel, Accommodations, Expenses - Novartis
 
Keith T. Flaherty
No Relationships to Disclose
 
Sunil Reddy
No Relationships to Disclose
 
Rahima Jamal
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)
 
Laura Q. Chow
Honoraria - Medscape; WebMD
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Seagen
Research Funding - AstraZeneca; Bristol-Myers Squibb; Genentech; Incyte; Merck; Novartis; Pfizer
 
Isabelle Anne Rooney
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Roche/Genentech
 
Bethany Pitcher
Employment - Roche
 
Edward Cha
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Jeffrey R. Infante
Research Funding - Aileron Therapeutics (Inst); ARMO BioSciences (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Calithera Biosciences (Inst); Celldex (Inst); Celldex (Inst); eFFECTOR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Janssen Oncology (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Phosplatin Therapeutics (Inst); Roche (Inst); Roche (Inst); Tesaro (Inst)